[1] |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J(Engl), 2022, 135: 584-590.
|
[2] |
Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understandings[J]. J Physiol, 2021, 599: 1745-1757.
|
[3] |
Ghosh P, Vidal C, Dey S, et al. Mitochondria targeting as an effective strategy for cancer therapys[J]. Int J Mol Sci, 2020, 21: 3363. doi: 10.3390/ijms21093363.
|
[4] |
Ashton TM, McKenna WG, Kunz-Schughart LA, et al. Oxidative phosphorylation as an emerging target in cancer therapys[J]. Clin Cancer Res, 2018, 24: 2482-2490.
|
[5] |
Gong Y, Ji P, Yang YS, et al. Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targetss[J]. Cell Metab, 2021, 33: 51-64.
|
[6] |
Swaminathan AB, Gohil VM. The role of COA6 in the mitochondrial copper delivery pathway to cytochrome c oxidases[J]. Biomolecules, 2022, 12: 125.doi: 10.3390/biom12010125.
|
[7] |
Baertling F, van den Brand MAM, Hertecant JL, et al. Mutations in COA6 cause cytochrome c oxidase deficiency and neonatal hypertrophic cardiomyopathys[J]. Hum Mutat, 2015, 36: 34-38.
|
[8] |
Luo H, Wang Z. Pan-cancer analysis reveals potential immunological and prognostic roles of COA6 in human cancers and preliminary exploration of COA6 in bladder cancers[J]. Cell Signal, 2024, 117: 111111.doi:10.1016/j.cellsig.2024.111111.
|
[9] |
Zhang M, Liao X, Ji G, et al. High expression of COA6 is related to unfavorable prognosis and enhanced oxidative phosphorylation in lung adenocarcinomas[J]. Int J Mol Sci, 2023, 24: 5705.doi: 10.3390/ijms24065705.
|
[10] |
Zhao X, Chen J, Yin S, et al. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosiss[J]. Front Oncol, 2022, 12: 992468.doi:10.3389/fonc.2022.992468.
|
[11] |
Stroud DA, Maher MJ, Lindau C, et al. COA6 is a mitochondrial complex IV assembly factor critical for biogenesis of mtDNA-encoded COX2[J]. Hum Mol Genet, 2015, 24: 5404-5415.
|
[12] |
Wintjes LTM, Kava M, van den Brandt FA, et al. A novel variant in COX16 causes cytochrome c oxidase deficiency, severe fatal neonatal lactic acidosis, encephalopathy, cardiomyopathy, and liver dysfunctions[J]. Hum Mutat, 2021, 42: 135-141.
|
[13] |
Zahalka AH, Arnal-Estapé A, Maryanovich M, et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancers[J]. Science, 2017, 358: 321-326.
|
[14] |
Fu C, Jiang A. Dendritic cells and CD8 T cell immunity in tumor microenvironments[J]. Front Immunol, 2018, 9: 3059.doi: 10.3389/fimmu.2018.03059.
|